Researchers at the University of Queensland are making significant strides toward developing a groundbreaking topical cream to prevent and treat skin cancers, specifically in organ transplant ...
Novel treatment allowed patients with colorectal cancer to successfully continue taking their cancer treatment with improved quality of life Acne-like skin rash is a common side effect from colorectal ...
Hoth Therapeutics' (HOTH) HT-001 Achieves 100% Response Rate in at least one endpoint in Phase 2a Trial in PK Patients for EGFR Inhibitor-Related Skin Toxicities. Hoth Therapeutics will host a Key ...
A research team from the UCLA Health Jonsson Comprehensive Cancer Center, the University of Texas MD Anderson Cancer Center, and collaborators have demonstrated that a novel topical BRAF inhibitor gel ...
Libtayo's approval for high-risk cutaneous squamous cell carcinoma offers a new immunotherapy option, targeting PD-1 ...
Dr. Clara Curiel-Lewandrowski is chair of the College of Medicine – Tucson’s Department of Dermatology and co-director of the U of A Cancer Center’s Skin Cancer Institute. Two researchers from the ...
Everyday Health on MSN
Atopic dermatitis: What to do if topical steroids aren't helping
Still itching after topical steroids? Here's why your atopic dermatitis symptoms may still be flaring and what you can do about it.
Non-melanoma skin cancer includes BCC, SCC, and the rare MCC, with BCC being the most common and MCC the most aggressive. Diagnosis involves skin examination and biopsy, with additional tests for MCC ...
Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical BRAF inhibitor gel called LUT014 ...
Researchers at the University of Arizona awarded federal funding to develop topical treatments that train immune system to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback